|
1
|
Morgan E, Soerjomataram I, Rumgay H,
Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J and Arnold
M: The global landscape of esophageal squamous cell carcinoma and
esophageal adenocarcinoma incidence and mortality in 2020 and
projections to 2040: New estimates from GLOBOCAN 2020.
Gastroenterology. 163:649–658.e2. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng RS, Chen R, Han BF, Wang SM, Li L,
Sun KX, Zeng HM, Wei WW and He J: Cancer incidence and mortality in
China, 2022. Zhonghua Zhong Liu Za Zhi. 46:221–231. 2024.(In
Chinese). PubMed/NCBI
|
|
3
|
Verstegen MH, Harker M, van de Water C,
van Dieren J, Hugen N, Nagtegaal ID, Rosman C and van der Post RS:
Metastatic pattern in esophageal and gastric cancer: Influenced by
site and histology. World J Gastroenterol. 26:6037–6046. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang H, Tang H, Fang Y, Tan L, Yin J, Shen
Y, Zeng Z, Zhu J, Hou Y, Du M, et al: Morbidity and mortality of
patients who underwent minimally invasive esophagectomy after
neoadjuvant chemoradiotherapy vs neoadjuvant chemotherapy for
locally advanced esophageal squamous cell carcinoma: A randomized
clinical trial. JAMA Surg. 156:444–451. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rice TW, Gress DM, Patil DT, Hofstetter
WL, Kelsen DP and Blackstone EH: Cancer of the esophagus and
esophagogastric junction-major changes in the American joint
committee on cancer eighth edition cancer staging manual. CA Cancer
J Clin. 67:304–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang F, Ge X, Wang Z, Weng Y, Yin R and
You Q: Clinical significance and prognosis of supraclavicular lymph
node metastasis in patients with thoracic esophageal cancer. Ann
Transl Med. 8:902020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park SY, Lee J, Jeon YJ, Cho JH, Kim HK,
Choi YS, Zo JI and Shim YM: Clinical and pathologic supraclavicular
lymph node metastases in esophageal squamous cell carcinoma treated
by esophagectomy with three-field lymph node dissection. Ann Surg
Oncol. 31:3399–3408. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mine S, Tanaka K, Kawachi H, Shirakawa Y,
Kitagawa Y, Toh Y, Yasuda T, Watanabe M, Kamei T, Oyama T, et al:
Japanese classification of esophageal cancer, 12th edition: Part I.
Esophagus. 21:179–215. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Numata Y, Abe T, Higaki E, Hosoi T,
Fujieda H, Nagao T, Hanai N, Suzuki H, Nishikawa D, Matsuo K, et
al: Should the supraclavicular lymph nodes be considered regional
lymph nodes in cervical esophageal cancer? Ann Surg Oncol.
29:616–626. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu Y, Xu L, Chen X, Li H, Liu Q, Zhang R,
Xie H, Chen Y, Yuan L, Tan B, et al: Neoadjuvant therapy combined
with surgery is superior to chemoradiotherapy in esophageal
squamous cell cancer patients with resectable supraclavicular lymph
node metastasis: A propensity score-matched analysis. Ann Transl
Med. 10:3492022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tachimori Y, Ozawa S, Numasaki H,
Matsubara H, Shinoda M, Toh Y and Udagawa H; Registration Committee
for Esophageal Cancer of the Japan Esophageal Society, :
Supraclavicular node metastasis from thoracic esophageal carcinoma:
A surgical series from a Japanese multi-institutional nationwide
registry of esophageal cancer. J Thorac Cardiovasc Surg.
148:1224–1229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Patel DC, Yang CJ, Liou DZ and Berry MF:
Treatment and outcomes of proximal esophageal squamous cell
carcinoma. Ann Surg Oncol. 30:818–827. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Zhang H, Wang L, Xie C, Yu H and
Zhong Y: Optimization of supraclavicular lymph node clinical target
volume delineation in high-risk breast cancer: A single center
experience and recommendation. BMC Cancer. 23:11682023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Zhang W, Zhang B, Qian D, Li X,
Zhang H, Wang Q, Zhao L, Pang Q and Wang P: Clinical results of
intensity-modulated radiotherapy for 250 patients with cervical and
upper thoracic esophageal carcinoma. Cancer Manag Res.
11:8285–8294. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Higgins MI and Master VA: Who really knows
the performance status: The physician or the patient? Cancer.
127:339–341. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Doki Y, Tanaka K, Kawachi H, Shirakawa Y,
Kitagawa Y, Toh Y, Yasuda T, Watanabe M, Kamei T, Oyama T, et al:
Japanese classification of esophageal cancer, 12th edition: Part
II. Esophagus. 21:216–269. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong Z, Wang D, Liu Y, Shao S, Chen S, He
S, Yang N, Li C, Ren J, Zhao Y, et al: Lymph drainage and cervical
fascia anatomy-oriented differential nodal CTV delineation at the
supraclavicular region for esophageal cancer and nasopharyngeal
cancer. Radiother Oncol. 177:113–120. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jing H, Tang Y, Wang ZZ, Wei R, Jin JY, Li
J, Zhao LY, Jin J, Liu YP, Song YW, et al: Individualized clinical
target volume for irradiation of the supraclavicular region in
breast cancer based on mapping of the involved ipsilateral
supraclavicular lymph nodes. Int J Radiat Oncol Biol Phys.
115:922–932. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luo Y, Liu Y, Wang X, Zhang B, Yu J, Wang
C, Huang Y and Li M: Mapping patterns of nodal metastases in
esophageal carcinoma: Rethinking the clinical target volume for
supraclavicular nodal irradiation. J Thorac Dis. 8:3132–3138. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu J, Ouyang W, Li C, Shen J, Xu Y, Zhang
J and Xie C: Mapping patterns of metastatic lymph nodes for
postoperative radiotherapy in thoracic esophageal squamous cell
carcinoma: A recommendation for clinical target volume definition.
BMC Cancer. 19:9272019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang W, Zhu M, Xiang Y, Sun Y, Li S, Cai
J and Zeng H: Current and future perspectives in unresectable
locally advanced esophageal squamous cell cancer (review). Oncol
Rep. 51:652024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bassalobre M, Liebano RE, da Silva MP,
Castiglioni MLV, Sadala AY, Ferreira LM and Nahas FX: Changes in
the pattern of superficial lymphatic drainage of the abdomen after
abdominoplasty. Plast Reconstr Surg. 149:1106e–1113e. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun JM, Shen L, Shah MA, Enzinger P,
Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, et al:
Pembrolizumab plus chemotherapy versus chemotherapy alone for
first-line treatment of advanced oesophageal cancer (KEYNOTE-590):
A randomised, placebo-controlled, phase 3 study. Lancet.
398:759–771. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu J, Yang Y, Liu Z, Fu X, Cai X, Li H,
Zhu L, Shen Y, Zhang H, Sun Y, et al: Multicenter, single-arm,
phase II trial of camrelizumab and chemotherapy as neoadjuvant
treatment for locally advanced esophageal squamous cell carcinoma.
J Immunother Cancer. 10:e0042912022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Okamura A, Watanabe M, Kozuki R, Toihata
T, Yuda M, Imamura Y and Mine S: Supraclavicular and celiac
metastases in squamous cell carcinoma of the middle thoracic
esophagus. Langenbecks Arch Surg. 403:977–984. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wen J, Chen D, Zhao T, Chen J, Zhao Y, Liu
D, Wang W, Xu X, Fan M, Chen C and Chen Y: Should the clinical
significance of supraclavicular and celiac lymph node metastasis in
thoracic esophageal cancer be reevaluated? Thorac Cancer.
10:1725–1735. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsunoda S, Hoshino N, Yoshida S and Obama
K: Prophylactic supraclavicular lymph node dissection for
esophageal squamous cell carcinoma: A systematic review and
meta-analysis. Surg Today. 53:647–654. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Y, Dong B, Zhu W, Li J, Huang R, Sun Z,
Yang X, Liu L, He H, Liao Z, et al: A phase III multicenter
randomized clinical trial of 60 Gy versus 50 Gy radiation dose in
concurrent chemoradiotherapy for inoperable esophageal squamous
cell carcinoma. Clin Cancer Res. 28:1792–1799. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumakura Y, Yokobori T, Yoshida T, Hara K,
Sakai M, Sohda M, Miyazaki T, Yokoo H, Handa T, Oyama T, et al:
Elucidation of the anatomical mechanism of nodal skip metastasis in
superficial thoracic esophageal squamous cell carcinoma. Ann Surg
Oncol. 25:1221–1228. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lei X, Cao Z, Wu Y, Lin J, Zhang Z, Jin J,
Ai Y, Zhang J, Du D, Tian Z, et al: Preoperative prediction of
clinical and pathological stages for patients with esophageal
cancer using PET/CT radiomics. Insights Imaging. 14:1742023.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Watanabe A, Taniguchi M, Kimura Y, Kikkawa
T and Hosokawa M: Larynx-preserving hybrid surgery with endoscopic
laryngopharyngeal surgery and open surgery for cervical esophageal
cancer invading pharynx. Dis Esophagus. 33:doaa0202020. View Article : Google Scholar : PubMed/NCBI
|
